These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33228460)

  • 61. Computational Study on the Enzyme-Ligand Relationship between Cannabis Phytochemicals and Human Acetylcholinesterase: Implications in Alzheimer's Disease.
    Vasquez R; Batista L; Cuya T
    J Phys Chem B; 2023 Oct; 127(41):8780-8795. PubMed ID: 37815196
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An
    Potshangbam AM; Nandeibam A; Amom T; Potshangbam N; Rahaman H; Rathore RS; Singh LR; Khan A
    J Biomol Struct Dyn; 2022 Mar; 40(4):1521-1533. PubMed ID: 33021148
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
    Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
    J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reviewing the role of donepezil in the treatment of Alzheimer's disease.
    Doody RS; Cummings JL; Farlow MR
    Curr Alzheimer Res; 2012 Sep; 9(7):773-81. PubMed ID: 22175653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
    Li Q; He S; Chen Y; Feng F; Qu W; Sun H
    Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
    Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization.
    Espinoza LC; Vacacela M; Clares B; Garcia ML; Fabrega MJ; Calpena AC
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):43-53. PubMed ID: 29299992
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies.
    Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M
    J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of Salvia miltiorrhiza on acetylcholinesterase: Enzyme kinetics and interaction mechanism merging with molecular docking analysis.
    Tang H; Song P; Li J; Zhao D
    Int J Biol Macromol; 2019 Aug; 135():303-313. PubMed ID: 31128195
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.
    Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z
    Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
    Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
    J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Computational insight into the anticholinesterase activities and electronic properties of physostigmine analogs.
    Adeniyi AA; Conradie J
    Future Med Chem; 2019 Aug; 11(15):1907-1928. PubMed ID: 31517530
    [No Abstract]   [Full Text] [Related]  

  • 77. Rational design for novel heterocyclic based Donepezil analogs for Alzheimer's disease: an in silico approach.
    Swain S; Sen A; Metya AK
    J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38260972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Donepezil-Inspired Multitargeting Indanone Derivatives as Effective Anti-Alzheimer's Agents.
    Singh JV; Thakur S; Kumar N; Singh H; Mithu VS; Singh H; Bhagat K; Gulati HK; Sharma A; Singh H; Sharma S; Bedi PMS
    ACS Chem Neurosci; 2022 Mar; 13(6):733-750. PubMed ID: 35195392
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients.
    Zhang N; Gordon ML
    Clin Interv Aging; 2018; 13():1963-1970. PubMed ID: 30349215
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.
    Okamura N; Funaki Y; Tashiro M; Kato M; Ishikawa Y; Maruyama M; Ishikawa H; Meguro K; Iwata R; Yanai K
    Br J Clin Pharmacol; 2008 Apr; 65(4):472-9. PubMed ID: 18070217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.